Publication Name	World Journal of Hepatology
Manuscript ID	22954
Country	United States

Received	2015-10-07 12:57
Peer-Review Started	2015-10-07 15:27
To Make the First Decision	2015-11-06 10:49
Return for Revision	2015-11-10 15:54
Revised	2015-12-19 16:58
Second Decision	2015-12-29 11:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-01-07 17:04
Articles in Press	2016-01-07 17:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-11 09:19
Publish the Manuscript Online	2016-01-15 09:49

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management
Manuscript Source	Invited Manuscript
All Author List	Avin Aggarwal, Ryan B Perumpail, Swetha Tummala and Aijaz Ahmed
Funding Agency and Grant Number
Corresponding Author	Aijaz Ahmed, MD, Associate Professor, Medical Director Liver Transplant Program, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 750 Welch Road, Suite 210, Palo Alto, Stanford, CA 94304, United States. aijazahmed@stanford.edu
Key Words	Chronic hepatitis E infection; Solid organ transplant; Immunosuppression; Ribavirin; Hepatitis E virus; Orthotopic liver transplantation
Core Tip	Hepatitis E virus (HEV) is an emerging pathogen in developed countries and an important cause of graft hepatitis in the post-orthotopic liver transplantation population that is often misdiagnosed either due to low index of suspicion or due to poor diagnostic assays. We recommend mandatory HEV testing in such cases, and careful treatment with modi-fication of immunosuppression, especially switching from calcineurin inhibitors to a different class. Ribavirin has shown to be increasingly successful in treating HEV infection and preventing graft failure from acute HEV infection, if diagnosed early.
Publish Date	2016-01-15 09:49
Citation	Aggarwal A, Perumpail RB, Tummala S, Ahmed A. Hepatitis E virus infection in the liver transplant recipients: Clinical pre­sentation and management. World J Hepatol 2016; 8(2): 117-122
URL	http://www.wjgnet.com/1948-5182/full/v8/i2/117.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i2.117

Full Article (PDF)	WJH-8-117.pdf
Full Article (Word)	WJH-8-117.doc
Manuscript File	22954-Review.docx
Answering Reviewers	22954-Answering reviewers.pdf
Audio Core Tip	22954-Audio core tip.wma
Conflict-of-Interest Disclosure Form	22954-Conflict-of-interest statement.pdf
Copyright License Agreement	22954-Copyright assignment.pdf
Peer-review Report	22954-Peer-review(s).pdf
Scientific Misconduct Check	22954-Scientific misconduct check.pdf
Scientific Editor Work List	22954-Scientific editor work list.pdf